LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

LLY

901.29

-0.96%↓

JNJ

235.03

-0.28%↓

ABBV

204.68

-0.16%↓

NVS

148.56

+0.66%↑

AZN

185.31

+0.58%↑

Search

Talphera Inc.

Suletud

0.73 -8.75

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.69

Max

0.81

Põhinäitajad

By Trading Economics

Sissetulek

-947K

-4.4M

Müük

1K

1K

Kasumimarginaal

-443,600

Töötajad

13

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+306.25% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

13. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-28M

32M

Eelmine avamishind

9.48

Eelmine sulgemishind

0.73

Talphera Inc. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

24. märts 2026, 18:58 UTC

Suurimad hinnamuutused turgudel

MDA Space Shares Drop After NASA Shifts Focus to Moon's Surface and Away From Space Station

24. märts 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

24. märts 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

24. märts 2026, 23:33 UTC

Market Talk
Uudisväärsed sündmused

Gold Rises, Boosted by Dollar Weakness -- Market Talk

24. märts 2026, 23:16 UTC

Market Talk

Venezuelan Opposition Leader Says Oil Output Could Reach 5 Million B/D -- Market Talk

24. märts 2026, 22:40 UTC

Tulu

Shanghai Fosun Pharmaceutical: Results Supported by Higher Rev From Innovative Drugs, Overseas Business >2196.HK

24. märts 2026, 22:40 UTC

Tulu

Shanghai Fosun Pharmaceutical 2025 Net CNY3.37B Vs. Net CNY2.77B >2196.HK

24. märts 2026, 22:40 UTC

Tulu

Shanghai Fosun Pharmaceutical 2025 Rev CNY41.50B Vs. CNY40.91B >2196.HK

24. märts 2026, 21:44 UTC

Market Talk

Global Equities Roundup: Market Talk

24. märts 2026, 21:44 UTC

Market Talk

Sandfire's New Bull Excited by Kalkaroo Copper Deposit -- Market Talk

24. märts 2026, 20:59 UTC

Tulu

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

24. märts 2026, 20:58 UTC

Uudisväärsed sündmused

Israel Hits Russian-Iranian Weapons Smuggling Route in the Caspian Sea -- WSJ

24. märts 2026, 20:50 UTC

Market Talk
Uudisväärsed sündmused

Energy & Utilities Roundup: Market Talk

24. märts 2026, 20:50 UTC

Market Talk
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

24. märts 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

24. märts 2026, 20:25 UTC

Tulu

This Palantir-Linked Drone Stock Was Flying Under the Radar -- Until Now -- Barrons.com

24. märts 2026, 20:15 UTC

Market Talk
Uudisväärsed sündmused

Global Commodities Roundup: Market Talk

24. märts 2026, 20:10 UTC

Market Talk

Canada Mortgage Arrears Linked to Labor Market Performance -- Market Talk

24. märts 2026, 20:10 UTC

Tulu

Worthington Enterprises 3Q Sales $378.7M >WOR

24. märts 2026, 20:10 UTC

Tulu

Worthington Enterprises 3Q Adj EPS 98c >WOR

24. märts 2026, 20:10 UTC

Tulu

Worthington Enterprises 3Q EPS 92c >WOR

24. märts 2026, 19:25 UTC

Market Talk
Uudisväärsed sündmused

Canada Needs Roughly 100 Days to Meet IEA's Oil-Stock Release -- Market Talk

24. märts 2026, 19:06 UTC

Market Talk
Uudisväärsed sündmused

Oil Futures Regain Ground As Strikes Continue in Middle East -- Market Talk

24. märts 2026, 18:51 UTC

Market Talk
Uudisväärsed sündmused

U.S. Natural Gas Settles Higher As Oil Futures Gain -- Market Talk

24. märts 2026, 18:40 UTC

Market Talk
Uudisväärsed sündmused

Global Forex and Fixed Income Roundup: Market Talk

24. märts 2026, 18:40 UTC

Market Talk
Uudisväärsed sündmused

Mideast Conflict to Hobble But Not Derail Canadian Economy -- Market Talk

24. märts 2026, 18:34 UTC

Uudisväärsed sündmused

Oil Production in the Middle East Will Take Months to Come Back, CEO says. Why $100 Oil Could Be Here to Stay. -- Barrons.com

24. märts 2026, 18:27 UTC

Market Talk

Inflation Pickup Could Keep Bank of Mexico on Hold -- Market Talk

24. märts 2026, 18:21 UTC

Market Talk
Uudisväärsed sündmused

Silver Snaps 9-Session Losing Streak -- Market Talk

24. märts 2026, 18:00 UTC

Omandamised, ülevõtmised, äriostud

Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Talphera Inc. Prognoos

Hinnasiht

By TipRanks

306.25% tõus

12 kuu keskmine prognoos

Keskmine 3.25 USD  306.25%

Kõrge 3.5 USD

Madal 3 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Talphera Inc. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Finantsandmed

Müügi- ja halduskulud

Maksueelne kasum

Müük

Intressikulud võla pealt

Ärikasum

$

Ettevõttest Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.
help-icon Live chat